Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Department of Respiratory Medicine, Zhongnan Hospital Wuhan University, Wuhan, Hubei, 361005, China.
Small. 2024 Apr;20(17):e2307365. doi: 10.1002/smll.202307365. Epub 2023 Nov 21.
In search of effective therapeutics for breast cancers, establishing physiologically relevant in vitro models is of great benefit to facilitate the clinical translation. Despite extensive progresses, it remains to develop the tumor models maximally recapturing the key pathophysiological attributes of their native counterparts. Therefore, the current study aimed to develop a microsphere-enabled modular approach toward the formation of in vitro breast tumor models with the capability of incorporating various selected cells while retaining spatial organization. Poly (lactic-co-glycolic acid) microspheres (150-200 mm) with tailorable pore size and surface topography are fabricated and used as carriers to respectively lade with breast tumor-associated cells. Culture of cell-laden microspheres assembled within a customized microfluidic chamber allowed to form 3D tumor models with spatially controlled cell distribution. The introduction of endothelial cell-laden microspheres into cancer-cell laden microspheres at different ratios would induce angiogenesis within the culture to yield vascularized tumor. Evaluation of anticancer drugs such as doxorubicin and Cediranib on the tumor models do demonstrate corresponding physiological responses. Clearly, with the ability to modulate microsphere morphology, cell composition and spatial distribution, microsphere-enabled 3D tumor tissue formation offers a high flexibility to satisfy the needs for pathophysiological study, anticancer drug screening or design of personalized treatment.
为了寻找乳腺癌的有效治疗方法,建立生理相关的体外模型对于促进临床转化非常有益。尽管已经取得了广泛的进展,但仍需要开发最大限度地再现其天然对应物关键病理生理特征的肿瘤模型。因此,本研究旨在开发一种基于微球的模块化方法,用于体外乳腺癌模型的形成,该模型具有同时包含各种选定细胞的能力,同时保留空间组织。制备了具有可调节孔径和表面形貌的聚(乳酸-共-乙醇酸)微球(150-200μm),并用作载体制备负载有乳腺癌相关细胞的微球。在定制的微流控室中培养载有细胞的微球,允许在空间上控制细胞分布形成 3D 肿瘤模型。以不同比例将内皮细胞负载的微球引入到癌细胞负载的微球中,可在培养物中诱导血管生成,从而产生血管化肿瘤。在肿瘤模型上评估抗癌药物(如多柔比星和 Cediranib)的实验表明,这些药物具有相应的生理反应。显然,通过调节微球形态、细胞组成和空间分布的能力,基于微球的 3D 肿瘤组织形成提供了高度的灵活性,以满足病理生理学研究、抗癌药物筛选或个性化治疗设计的需求。